Contact Us
Drug Search Results
More Filters [+]

Nicergoline

Alternative Names: nicergoline
Latest Update: 2024-11-14
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: ADRA1A Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Brazil | Bulgaria | Chile | Dominican Republic | Egypt | Germany | Hong Kong | Hungary | India | Indonesia | Italy | Jordan | Korea | Latvia | Lithuania | Mexico | Pakistan | Peru | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Slovenia | Spain | Taiwan | Turkey | Ukraine | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nicergoline

Countries in Clinic: China

Active Clinical Trial Count: 3

Highest Development Phases

Phase 1: Cognition Disorders|Dementia, Vascular|Depressive Disorder|Ischemic Stroke|Memory Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CTR20200610

P1

Not yet recruiting

Dementia, Vascular|Cognition Disorders|Ischemic Stroke|Memory Disorders|Depressive Disorder

None

CTR20200609

P1

Not yet recruiting

Depressive Disorder|Memory Disorders|Cognition Disorders|Ischemic Stroke|Dementia, Vascular

None

CTR20230590

P1

Not yet recruiting

Dementia, Vascular|Ischemic Stroke|Depressive Disorder

None

Recent News Events

Date

Type

Title

08/01/2023

PubMed

 Apoptosis in Alzheimer's disease: insight into the signaling pathways and therapeutic avenues.

03/01/2023

PubMed

 Concomitant Bandage Contact Lens, Oral Nicergoline, and Topical Autologous Serum for Severe Neurotrophic Keratitis.

01/01/2023

PubMed

 [Study of the effect of Unifuzol on cognitive impairment and damage to the hippocampus and cerebral cortex during course administration to rats with bilateral stenosis of the common carotid arteries, causing chronic circulatory failure].

09/22/2021

News Article

 Bromine Market worth $4.1 billion by 2026 - Exclusive Report by MarketsandMarkets™

10/20/2020

News Article

 Increasing demand for bromine in flame retardants and mercury emission control is expected to drive the bromine industry growth

07/16/2020

News Article

 Bromine Market Worth $4.1 Billion by 2025 - Exclusive Report by MarketsandMarkets™

11/14/2019

News Article

 Bromine Market Worth $USD 4.4 Billion by 2024 - Exclusive Report by MarketsandMarkets™

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions